Helius Medical Technologies Inc. - HSDT Projected Future Earnings
The prospects for Helius Medical (HSDT) depend on insurance companies recognizing the PoNS system as a rehabilitation standard. Projected operating profit reflects current market expectations, where the 0.00 mark characterizes this parameter. While assembly automation improves device reliability, a narrow specialization in a single product and capital constraints create certain financial risks.
Analytical breakdowns and data insights for company Helius Medical Technologies Inc. (HSDT)
- share price and consensus valuation forecast:
- issuer market value details:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Helius Medical|HSDT - Long-Term Debt to Capital|Short-Term Debt to Equity Helius Medical Technologies|HSDT - Company Total Debt Obligations|Debt to Book Value Helius Medical Technologies Inc.|HSDT - Company Long-Term Loans and Borrowings|Company Short-Term Debt Helius Medical Technologies|Quick Ratio heliusmedical.com
- net income and valuation ratios data:
HSDT - Company Net Income|Projected Future Earnings Helius Medical|HSDT - Price to Earnings Multiple|Forward P/E Multiple Helius Medical Technologies|HSDT - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Helius Medical Technologies Inc.|HSDT - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Helius Medical Technologies|HSDT - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months heliusmedical.com|HSDT - Earnings per share growth in current year|Earnings growth forecast for next year Helius Medical
- company sales and revenue statistics:
Initial company analysis:Helius Medical Technologies, Inc.
Selecting assets with a high margin of safety requires an analysis of forward-looking metrics. This indicator measures aggregate market expectations regarding net income, separating the fundamental trend from short-term volatility. For Helius Medical (HSDT), profit growth depends on the expansion of neurostimulators within US clinics without pursuing mergers. The trend in the company's expected earnings reflects investor confidence in the success of this strategy. Analysis based on expected company earnings helps determine the optimal entry point.
Competitor analysis for Helius Medical
BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|Expected Net Profit Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Expected Profit|DNLI (Denali Therapeutics Inc) - Expected Profit|Expected Profit Harmony Biosciences Holdings, Inc.|Expected Profit BHVN|Future Profit AMLX (Amylyx Pharmaceuticals, Inc.)|Future Net Profit TRVI|Expected Profit Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Expected Profit|CBLL: Future Profit|Expected Net Income PRTA (prothena.com)|Alector, Inc. (ALEC) - Expected Profit|Net Profit Forecast ANNX|Expected Profit Omeros Corp.|Neurogene Therapeutics (NGNE) - Company Profit Forecast|Projected Future Earnings ACIU|VYGR (Voyager Therapeutics) - Expected Net Income|Projected Future Earnings NMRA (neumoratx.com)|SCLX: Net Profit Forecast|TVGN - Expected Profit|Expected Net Profit Alpha Cognition Inc.|CGTX: Projected Future Earnings|inhibikase.com (IKT) - Projected Future Earnings|Expected Profit Cassava Sciences Inc|ASRT - Projected Net Profit|Expected Profit Coya (COYA)|Projected Future Earnings VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Future Profit|Company Profit Forecast Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Projected Future Earnings|Company Profit Forecast alteritytherapeutics.com ATHE|CLNN: Projected Future Earnings|Expected Net Profit PepGen Corp (PEPG)|Expected Profit Jupiter Neurosciences, Inc.|RLMD: Expected Net Income|Projected Future Earnings ANVS|Future Profit Grace Tx GRCE|Expected Profit Firefly Neuroscience, Inc AIFF|KLTO: Net Profit Forecast|NRSN - Expected Profit|RVPH: Expected Profit|MTVA (MetaVia Inc.) - Future Profit|NeurAxis Inc. (NRXS) - Projected Future Earnings|Expected Profit Passage Bio Corp|Future Profit Neuphoria Therapeutics (NEUP)|Projected Future Earnings NERV|ATHA - Expected Net Profit|Projected Future Earnings ADXN (addextherapeutics.com)|Alzamend (ALZN) - Expected Net Profit|CYCN: Future Profit|Expected Net Profit Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Expected Profit|Expected Net Profit Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Projected Future Earnings|BCLI (Brainstorm Cell Therapeutics Inc.) - Future Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics - Future Profit|Intra-Cellular (ITCI) - Expected Net Profit|LBPH - Expected Profit|MRNS - Projected Future Earnings|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)
